Viewing Study NCT04810767


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2025-12-25 @ 10:58 PM
Study NCT ID: NCT04810767
Status: UNKNOWN
Last Update Posted: 2021-09-21
First Post: 2021-03-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Chronic Pain After CS in Egypt
Sponsor: Bahaa Mohammed Refaie
Organization:

Study Overview

Official Title: Prevalence and Risk Factors for Chronic Pain After Cesarean Delivery in Upper Egypt: Retrospective Study
Status: UNKNOWN
Status Verified Date: 2021-09
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This retrospective study will include Women who will attending to Azhar assuit, Sohag and South valley universities hospitals for any reason in the duration from 1 May to 31 October 2021, and who underwent elective CD under spinal anesthesia with horizontal lower abdominal surgical incision within last two years.

Exclusion criteria will be refusal to participate, age less than 18 years, recent CD (within 3 months), if the infant had died, and history of chronic pain medications or psychiatric disorder.

Data collection

Participants will be contacted personally by one of study authors. Data collected are consisted of:

* Participants' characteristics as Age, parity and ways of delivery, weight, height, residency, husband smoking status, work, previous abdominal surgery, history of diabetes mellitus and hypertension.
* Last CD related data which include presence of multiple pregnancies, if CD was in private/public facility, presence surgical wound infection.
* Pain experienced will be assessed by questionnaire described by Nikolajsen et al, 2004
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: